Mohs surgery removes skin cancer with a 98–99% success rate in a single visit. Radiation therapy treats cancer non-invasively over 4–7 weeks, with cure rates around 90–95%. Patients with facial tumors or aggressive cancers benefit from Mohs. Those with thin skin, bleeding risks, or age-related concerns often choose radiation.
At Cosmetic Skin’s dermatology, both options are available. Treatment choice depends on cancer type, health status, recovery goals, and cosmetic concerns. Compare both methods below to decide confidently.
What Is Mohs Surgery and When Is It Used?
Mohs surgery removes skin cancer layer by layer, examining each sample immediately under a microscope until no cancer cells remain. This technique targets visible and microscopic spread with high accuracy.
Surgeons use Mohs for basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), especially on the nose, eyelids, ears, or lips, areas where preserving healthy tissue matters most. Patients with recurring or aggressive tumors benefit from its control over margin clearance. Mohs achieves 98–99% success for primary BCC and up to 94% for recurrent cases. Procedures occur in the office, under local anesthesia, and are completed within a day.
At Cosmetic Skin, board-certified specialist Dr. Quan performs all Mohs surgeries, combining oncologic precision with cosmetic outcomes, particularly in sensitive facial zones.
What Is Image-Guided Radiation Therapy for Skin Cancer?
Radiation therapy treats skin cancer by directing low-dose X-rays at the tumor site, damaging cancer cell DNA and halting growth. Image-guided superficial radiation therapy (SRT) improves accuracy using real-time imaging.
SRT treats early-stage BCC and SCC without scalpels, anesthesia, or bleeding. It delivers targeted energy to the tumor and surrounding margin, sparing deeper tissues. Sessions take place 3–5 times a week over several weeks, with cumulative results. Patients with thin skin, bleeding risk, or poor wound healing, especially those over 65, often tolerate radiation better than surgery.
Cosmetic Skin uses GentleCure®, an FDA-cleared SRT system with a 93–95% cure rate for select cases. Treatment is painless, outpatient-based, and avoids surgical recovery.
Surgical vs. Non-Surgical Skin Cancer Treatment: A Direct Comparison
Mohs surgery removes cancer through surgical excision. SRT treats cancer non-invasively with cumulative radiation. Both options offer strong results depending on the clinical context.
| Factor | Mohs Surgery | Radiation Therapy (SRT) |
| Type | Surgical, one-day procedure | Non-invasive, 4–7 week protocol |
| Cure Rate (BCC) | 98–99% | 90–95% |
| Invasiveness | Requires excision | No incision or needles |
| Downtime | 7–14 days recovery | Minimal, spread across sessions |
| Ideal Use | Facial tumors, recurrence | Elderly, thin skin, bleeding risk |
| Setting | In-office surgical suite | Outpatient imaging & therapy room |
Patients with visible tumors on the face or a history of recurrence often achieve better outcomes with Mohs. Patients prioritizing comfort, reduced risk, or who are ineligible for surgery may benefit from radiation.
What Are the Five-Year Cure Rates for Mohs and Radiation?
Mohs surgery offers the highest five-year cure rate for localized BCC and SCC, averaging 98–99% for new tumors and 94% for recurrences. Immediate margin control prevents residual Who Should Choose Mohs Surgery Over Radiation Therapy?
cancer from remaining undetected.
Radiation therapy achieves 90–95% five-year cure rates for small, superficial cancers when delivered in precise, fractionated doses. Image guidance like that used in GentleCure improves targeting and reduces recurrence risk.
Studies published in 2025 show improved outcomes in SRT-treated elderly populations, especially where tumors were on the scalp or near the eye. However, aggressive or infiltrative tumors respond better to surgical control via Mohs.
Patients under 70 with accessible tumors and good overall health benefit most from Mohs surgery. It provides one-day resolution, cosmetic tissue preservation, and the highest cure rates. Mohs is preferred when tumors are:
- Located on the face (nose, eyelids, ears, lips)
- Previously treated or recurrent
- Aggressive in pathology
- Near cosmetically or functionally sensitive areas
Radiation therapy works well for patients with:
- Age over 65
- Bleeding disorders or on anticoagulants
- Diabetes or slow wound healing
- Personal preference to avoid surgery
- Superficial tumors are unsuitable for surgical margins
Treatment success depends not only on tumor biology but also on patient factors. At Cosmetic Skin, clinicians provide both options with individualized care plans that prioritize health and appearance.
How Does Cosmetic Impact Differ Between Mohs and Radiation?
Mohs surgery preserves more healthy tissue than standard excision, reducing scar size. Surgeons excise only cancerous cells while monitoring margins under a microscope, allowing maximum skin preservation. For tumors on the nose, eyelids, lips, or ears, Mohs achieves both cancer removal and favorable cosmetic results. Post-operative reconstruction, often performed the same day, further enhances appearance.
Radiation therapy avoids surgical scars entirely but may lead to cosmetic changes over time. Common effects include skin thinning, pigmentation changes, or surface dryness. These changes develop gradually and may last months or longer, depending on the treatment area and dosage.
Patients concerned with visual appearance in high-profile areas benefit from discussing both options at Cosmetic Skin. Our team balances oncologic control with cosmetic outcomes in every treatment decision.
Are There Alternatives to Mohs and Radiation Therapy?
Patients with low-risk, superficial tumors may qualify for other localized treatments, though these offer lower precision and variable cure rates.
- Cryotherapy freezes tumor tissue using liquid nitrogen. It works best for small lesions but may cause pigment loss or incomplete treatment in deeper cancers.
- Curettage and Electrodessication scrape and cauterize superficial skin cancers but lack margin verification, raising recurrence risks.
- Photodynamic Therapy (PDT) uses light-activated medication to destroy cancer cells in the skin’s upper layers. It works well for actinic keratoses or carcinoma in situ.
- Topical Medications such as 5-fluorouracil (5-FU) or Imiquimod treat certain early-stage superficial BCCs or pre-cancers but require extended daily application and monitoring.
Cosmetic Skin specialists recommend these options only when appropriate, ensuring treatment matches both medical need and long-term safety.
Ready to Take the Next Step? Consult Our Experts
Schedule your consultation with Cosmetic Skin to discuss your treatment plan. Whether you need Mohs micrographic surgery or image-guided radiation therapy, our team provides trusted care at four convenient New Jersey locations: Englewood Cliffs, Old Bridge, Jersey City, and Secaucus.
Contact us today to receive personalized guidance from board-certified dermatologists committed to both cancer removal and skin preservation.
Frequently Asked Questions
Can skin cancer return after Mohs or radiation therapy?
Yes. Although both treatments offer high cure rates, recurrence can occur, especially in aggressive tumors. Regular follow-ups every 6–12 months help detect new or returning skin cancers early.
Does radiation therapy affect healthy skin around the tumor?
Yes. Radiation targets the tumor and a small surrounding margin. While modern imaging reduces exposure, nearby skin may experience dryness, redness, or pigment changes during or after treatment.
What are the long-term side effects of superficial radiation therapy?
Long-term effects may include mild scarring, skin thinning, or pigment loss. These changes typically appear months after treatment and are more common in areas with delicate or sun-damaged skin.
How soon can I resume normal activities after Mohs surgery?
Most patients return to routine activities within 1–2 days. Strenuous exercise or sun exposure should be avoided until the surgical site heals, which typically takes 1–2 weeks
Is anesthesia required for radiation therapy?
No. Radiation therapy does not require anesthesia. Sessions are painless and performed while the patient is awake, making it suitable for individuals who cannot undergo sedation or surgery.